Medtronic (MDT) Set to Announce Quarterly Earnings on Tuesday
Medtronic (NYSE:MDT) will be announcing its earnings results on Tuesday, February 18th. Medtronic has set its FY14 guidance at $3.80-3.85 EPS.Parties interested in participating in the company’s conference call can do so using this link.
Medtronic (NYSE:MDT) last posted its quarterly earnings results on Tuesday, November 19th. The company reported $0.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.90 by $0.01. The company had revenue of $4.20 billion for the quarter, compared to the consensus estimate of $4.18 billion. During the same quarter in the previous year, the company posted $0.88 earnings per share. The company’s revenue for the quarter was up 2.4% on a year-over-year basis. On average, analysts expect Medtronic to post $3.82 EPS for the current fiscal year and $4.10 EPS for the next fiscal year.
Shares of Medtronic (NYSE:MDT) opened at 56.88 on Monday. Medtronic has a 1-year low of $43.51 and a 1-year high of $60.93. The stock has a 50-day moving average of $57.57 and a 200-day moving average of $55.97. The company has a market cap of $56.786 billion and a P/E ratio of 15.13.
The company also recently announced a quarterly dividend, which is scheduled for Friday, April 25th. Shareholders of record on Friday, April 4th will be paid a dividend of $0.28 per share. This represents a $1.12 annualized dividend and a dividend yield of 1.97%. The ex-dividend date is Wednesday, April 2nd.
MDT has been the subject of a number of recent research reports. Analysts at Barclays raised their price target on shares of Medtronic from $62.00 to $64.00 in a research note on Thursday, January 9th. They now have an “equal weight” rating on the stock. On the ratings front, analysts at BTIG Research initiated coverage on shares of Medtronic in a research note on Tuesday, January 7th. They set a “neutral” rating on the stock. Finally, analysts at Credit Suisse raised their price target on shares of Medtronic from $62.00 to $64.00 in a research note on Monday, January 6th. Nine analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. Medtronic presently has an average rating of “Buy” and an average price target of $61.06.
Medtronic, Inc (NYSE:MDT) is engaged in medical technology – alleviating pain, restoring health, and extending life for millions of people worldwide.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.